Ozanimod Recruiting Phase 3 Trials for Ulcerative Colitis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02435992Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
NCT02531126Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
NCT03915769To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis